Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | METAP1 | P53582 | 4/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30785363 | 1.00 | ACHE (0.55) | ACHECYP19A1LMNATP53CYP1A2 | |
| SCHEMBL13176510 | 0.85 | KDM4E (0.53) | ACHECYP19A1TP53CYP1A2CYP3A4 | |
| SCHEMBL2920960 | 0.85 | CYP19A1 (0.56) | ACHECYP19A1MAPTMETAP1SMN1; SMN2 | |
| SCHEMBL8001882 | 0.85 | RAB9A (0.53) | ACHECYP19A1LMNAMAPTMAPK1 | |
| SCHEMBL30424074 | 0.81 | METAP1 (0.49) | ACHECYP19A1MAPTMAPK1METAP1 | |
| SCHEMBL14939674 | 0.81 | HTR2A (0.47) | ACHECYP19A1LMNAMAPTHTR2B | |
| SCHEMBL30423621 | 0.81 | ACHE (0.49) | ACHECYP19A1MAPTMETAP1 | |
| SCHEMBL14939220 | 0.81 | CYP19A1 (0.59) | ACHECYP19A1LMNATP53MAPT | |
| SCHEMBL31751995 | 0.81 | CYP19A1 (0.59) | ACHECYP19A1MAPTMETAP1 | |
| SCHEMBL9148955 | 0.81 | CYP19A1 (0.59) | ACHECYP19A1LMNATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0790076-B1 | Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use | BASELL POLYOLEFINE GMBH (DE) | 2001-12-05 | — | — | EP | claimed |
| EP-0790076-A2 | Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-08-20 | — | — | EP | claimed |
| US-4578509-A | Process for preparing a manipulated enantiomer mixture by asymmetric chiral phase transfer catalysis | MERCK & CO., INC. (US) | 1986-03-25 | — | — | US | claimed |
| EP-0121872-A1 | Process for preparing a manipulated enantiomer mixture by asymmetric chiral phase transfer catalysis | MERCK & CO. INC. (US) | 1984-10-17 | — | — | EP | claimed |
| JP-1075443-A | — | — | None | — | — | JP | disclosed |
| US-20250387546-A1 | LUBRICIOUS COATED MEDICAL DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| CN-118221849-B | Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax | 亚培烯科技(上海)有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118221849-A | Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax | 亚培烯科技(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-114375291-B | Novel compounds for skin lightening | 联合利华知识产权控股有限公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-3790604-A1 | LUBRICIOUS COATING COMPOSITIONS | Boston Scientific Scimed Inc. (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-3021882-B2 | LUBRICIOUS COATING COMPOSITIONS | BOSTON SCIENT SCIMED INC (US) | 2021-01-27 | — | — | EP | disclosed |
| CN-110621345-A | Pulmonary hypertension treatment | 索尼维有限公司 | 2019-12-27 | — | — | CN | disclosed |
| US-5770753-A | ADDITION POLYMERIZATION CATALYST | TARGOR GMBH (DE) | 1998-06-23 | — | — | US | disclosed |
| EP-0228145-B1 | POLYPHOTOINITIATORS | LOCTITE CORPORATION (US) | 1992-03-18 | — | — | EP | disclosed |
| US-5093498-A | Trifluoromethylbenzyl containing quaternary salts | MERCK & CO., INC. (US) | 1992-03-03 | — | — | US | disclosed |
| JP-S6475443-A | PRODUCTION OF INDANONE DERIVATIVE | SEKISUI CHEMICAL CO LTD | 1989-03-22 | — | — | JP | disclosed |
| EP-0228145-A1 | Polyphotoinitiators | LOCTITE CORPORATION (US) | 1987-07-08 | — | — | EP | disclosed |
| US-4587276-A | Polyphotoinitiators | LOCTITE CORPORATION (US) | 1986-05-06 | — | — | US | disclosed |
| US-4578509-A | Process for preparing a manipulated enantiomer mixture by asymmetric chiral phase transfer catalysis | MERCK & CO., INC. (US) | 1986-03-25 | — | — | US | disclosed |
| EP-0121872-A1 | Process for preparing a manipulated enantiomer mixture by asymmetric chiral phase transfer catalysis | MERCK & CO. INC. (US) | 1984-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387546-A1 | LUBRICIOUS COATED MEDICAL DEVICES | UFM1, PWWP2B, UFL1 | ACHE 4653/4885CYP19A1 3291/4885LMNA 4376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.